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AbstrACt
Introduction Research into interventions to improve 
health and well-being for older people living in care homes 
is increasingly common. Health-related quality of life 
(HRQoL) is frequently used as an outcome measure, but 
collecting both self-reported and proxy HRQoL measures 
is challenging in this setting. This study will investigate the 
reliability of UK care home staff as proxy respondents for 
the EQ-5D-5L and HowRu measures.
Methods and analysis This is a prospective cohort 
study of a subpopulation of care home residents recruited 
to the larger Proactive Healthcare for Older People in 
Care Homes (PEACH) study. It will recruit residents ≥60 
years across 24 care homes and not receiving short 
stay or respite care. The sample size is 160 participants. 
Resident and care home staff proxy EQ-5D-5L and 
HowRu responses will be collected monthly for 3 months. 
Weighted kappa statistics and intraclass correlation 
adjusted for clustering at the care home level will be 
used to measure agreement between resident and proxy 
responses. The extent to which staff variables (gender, 
age group, length of time caring, role, how well they know 
the resident, length of time working in care homes and in 
specialist gerontological practice) influence the level of 
agreement between self-reported and proxy responses will 
be considered using a multilevel mixed-effect regression 
model.
Ethics and dissemination The PEACH study protocol 
was reviewed by the UK Health Research Authority and 
University of Nottingham Research Ethics Committee and 
was determined to be a service development project. 
We will publish this study in a peer-reviewed journal 
with international readership and disseminate it through 
relevant national stakeholder networks and specialist 
societies.
IntroduCtIon 
Long-term care facilities in the UK are called 
care homes and are classified as either care 
homes with or without nursing based on the 
availability of registered nurses on-site.1 The 
types of residents cared for in both classifi-
cations of facility are similar and all UK care 
homes are included in the international 
consensus definition of a nursing home.2 
Around 425 000 people live in care homes in 
the UK3 with most residents requiring care 
due to disability from long-term conditions. 
The majority of residents are aged over 85, 
75–80% of residents live with dementia4 and 
over half of residents die within 12 months of 
admission to care home.5 
strengths and limitations of this study
 ► To our knowledge, this is the first study to investi-
gate the reliability of staff proxy using the EQ-5D-5L 
and HowRu and the reliability of HowRu as a quality 
of life measure in a UK care home setting.
 ► The scales will be administered to residents and 
staff on the same day, thus reducing any variations 
that will affect the level of agreement.
 ► Analysing the characteristics of staff respondents 
will help to generate insights into how proxies might 
better be selected or prepared to maximise the va-
lidity of proxy responses.
 ► The use of multiple time points will help to increase 
the sample size and account for the influence of 
staff turnover on the quality of proxy response.
 ► Working with residents with mental capacity will 
optimise their responses as a gold standard against 
which proxies can be compared. The way in which 
staff interpret quality of life in this more communica-
tive and able group may, however, be different to the 
way in which the interpret quality of life in advanced 
dementia.
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Improving the quality of care for older people in long-
term care has become a focus of attention for health and 
social care providers, both within the UK and internation-
ally,2 and an increasing number of evaluative research 
studies are being published that test the effectiveness 
and cost-effectiveness of interventions in this setting. 
Residents’ quality of life (QoL) is frequently used as an 
outcome measure in these studies both to maintain a 
patient-centred focus and to facilitate health economic 
evaluation. The prevalent frailty and cognitive impair-
ment in the care home population, however, means that 
collecting self-reported QoL measures from residents 
is challenging. As a response to this, proxy responses 
to QoL items have sometimes been used. For these a 
consultee, drawn from one of care home staff, or a rela-
tive or friend, answers questions on the resident’s behalf. 
Using proxy respondents can be unreliable in care home 
settings. There may be lack of continuity of care home 
staff contact with individual residents due to shift working 
and staff turnover, and family and friends may not be well 
placed to judge QoL domains if they visit residents for 
only short periods.6
The EuroQoL questionnaire is a widely used pref-
erence-based health-related quality of life (HRQoL) 
measure suitable for use in economic evaluations. The 
EQ-5D-5L version measures HRQoL across five domains 
(mobility, self-care, usual activities, pain and anxiety/
depression) with the scale for each domain ranging from 
level 1 (no problems) to level 5 (extreme problems). The 
responses from the five domains are converted to QoL 
index scores (utilities) generated from a given country’s 
general population.7 These index scores can be used to 
calculate quality-adjusted life years (QALYs), which are 
a measure of the person’s state of health—one QALY 
equates to 1 year in perfect health. QALYs are calcu-
lated using the area under the curve8 defined by utility 
scores at the different assessment points over the study 
period. The cost per QALY gained from an intervention 
when compared with usual care is the chosen cost-utility 
measure for determining eligibility for public support 
of the intervention through the UK National Health 
Service.9
The scale for the first version of EQ-5D had only three 
levels (EQ-5D-3L). EQ-5D-3L has been shown to have 
good construct validity for self-report10 and has been used 
to measure QoL of older people living in their own homes 
and in care homes.11 The 5L version was developed subse-
quently to deal with identified issues with sensitivity and a 
ceiling effect on the EQ-5D-3L which limited its ability to 
discriminate between health states, particularly in those 
with higher QoL.12 There is also an EQ-5D visual analogue 
scale (VAS) used to assess overall health status, ranging 
from 0 (worst imaginable) to 100 (best imaginable). VAS 
is recognised to have specific strengths and weaknesses13 
but is recommended to be used routinely alongside the 
self-classification questionnaire by the EuroQoL group 
because of its usefulness in establishing global health 
status.14
It is recognised that the EQ-5D, in all its forms, is 
limited by consequence of being a generic measure that 
fails to take account of the difference in what constitutes 
‘QoL’ in a long-term care setting. It doesn’t take account 
of shifts in emphasis about what constitutes well-being as 
residents enter long-term care, which means that social 
care-related quality of life measures such as the Adult 
Social Care Outcomes Toolkit may be preferable in this 
setting.15 16 A further critique has been that it fails to 
separate capability (what a resident is able to do) from 
preference (what a resident chooses to do under the 
circumstances), with the result that some authors have 
championed capability-based outcome measures, such as 
the ICEpop capability measure for older people, in care 
homes.17 18 Best practice suggests that, if EQ-5D is used in 
this setting, it is used in combination with more specific 
instruments.
The R-outcome tool howRu has been specifically 
designed for use in long-term care settings in order to 
address QoL in a straightforward way that is practical 
with older people. HowRu is a patient-recorded outcome 
measure (PROM) that records four variables (pain or 
discomfort, feeling low or worried, limitation in activi-
ties and dependency on others) related to QoL at a fixed 
point in time (‘How are you doing today?”) on a four-
point scale (none, slight, quite a lot, extreme).19 20 The 
HowRu score is calculated by summing up the values for 
each domain to give a value on a 13-point scale ranging 
from 0 (worst) to 12 (best). The HowRu PROM was 
designed with older adults in mind19 20 and may have a 
cogency and immediacy that improves on some of the 
measurement uncertainty introduced by the relative 
abstraction of the questions included in highly validated 
general population indices such as EQ-5D-5L.
In a comparison with EQ-5D in patients attending a 
cardiovascular outpatient clinic, HowRu was reported 
to have better readability, higher completion rate, wider 
range of states used and smaller ceiling effect.17 No 
national tariffs exist to enable calculation of HowRu 
indices that would facilitate its use as a preference-based 
measure in cost-utility analysis. Understanding how and 
whether R outcomes correlate with EQ-5D scores in the 
care home setting is, however, helpful when considering 
additional information that can help to triangulate our 
understanding of how interventions affect QoL in this 
context. Knowing that HowRu correlates with EQ-5D may 
provide further justification for using it in clinical settings 
where broad judgements about impact on QoL have to 
be made without the need for detailed cost-utility analysis.
Proxies have been used to capture EQ-5D-3L responses 
from people with dementia, although poor agreement 
between patient and proxy ratings has raised concerns15 16 
and differences between professional and family carer 
ratings have led to questions about the appropriate 
choice of proxy.16 In a comparison of clinicians and family 
carers as proxies, clinician responses had better construct 
validity in the more observable domains of mobility and 
self-care, and family carer responses had better construct 
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validity in the less observable domains of usual activities 
and anxiety/depression.16 There is limited evidence, 
however, comparing self-reported and proxy responses to 
the EQ-5D-5L in care home populations.17 There is, in 
particular, a paucity of data as to how it performs in UK 
care home populations. This is important because institu-
tional care is structured differently between nations, with 
differing professional carer competencies, patterns of 
working and job roles. This means that carers in different 
countries will have differential exposure to residents and 
different competencies in terms of their ability to inter-
pret residents’ experiences, and a tool that works for 
professional proxy response in the USA may not, there-
fore, work as well in the UK.
The HowRu, as a recently developed PROM, is yet to be 
fully evaluated for older people living in care homes.21 It 
is not known whether proxy responses in this setting may 
be useful in completing HowRU, and there are no data 
on how HowRu correlates with EQ-5D in the care home 
populations.
This study seeks to fill these evidence gaps.
AIM
The Assessing Proxy Reliability In Care home Outcome 
Testing (APRICOT) study is a preparatory piece of work 
for the Proactive Healthcare for Older People Living in 
Care Homes (PEACH) study. It aims to examine the level 
of agreement between the responses to EQ-5D-5L and 
HowRu by care home staff and residents and between 
EQ-5D-5L and HowRu as QoL measures. Findings will 
assist in the interpretation of QoL data gathered for the 
larger PEACH study.
objECtIvEs
To determine the level of agreement between:
 ► Resident EQ-5D-5L and staff proxy EQ-5D-5L 
responses.
 ► Resident HowRu and staff proxy HowRu responses.
 ► Resident EQ-5D-5L and HowRu responses.
 ► Proxy EQ-5D-5L and HowRu responses.
MEthods
setting
Twenty-four care homes in the East Midlands area of 
England. These are long-term care institutions, housing 
predominantly older people with frailty who can no 
longer be cared for at home. Detailed descriptions of the 
UK care home sector and the residents living within it 
have been published elsewhere.4
brief description of the PEACh study
The PEACH intervention involves using quality improve-
ment collaboratives as a mechanism to encourage imple-
mentation of comprehensive geriatric assessment (CGA) 
as a unifying framework for assessment and delivery of 
healthcare in UK care homes. CGA is widely recognised as 
a gold standard way to deliver care for older people with 
frailty.22 The aim of PEACH is to improve quality of care 
and QoL for care home residents. Outcome data quanti-
fying healthcare resource use and resident level QoL will 
be collected on a monthly basis to assess the impact of the 
intervention.
Two instruments are being used in PEACH to assess 
residents’ QoL, the EQ-5D-5L and HowRu. The rationale 
is that these reflect measurable differences in the patient 
experience that may translate, with some interpretation, 
into an understanding of how CGA influences quality of 
care and general well-being. APRICOT has been designed 
as a preparatory substudy within PEACH to better enable 
interpretation of proxy EQ-5D-5L and HowRU responses 
collected as part of outcome measurement.
Participants
Care home recruitment for PEACH took place between 
October 2016 and January 2017, with individual resident 
recruitment from January 2017. A prospective cohort 
of a subpopulation of residents will be included in the 
comparison of proxy and self-report measurement of 
EQ-5D-5L and HowRu in APRICOT. Residents included 
in the study will be those ≥60 years across 24 care homes 
and not receiving short stay or respite care. To have a 
better reflection of self-reported and proxy agreement 
in a care home setting, we will include residents with 
and without mental capacity. Care home managers will 
provide guidance with regards to residents with and 
without capacity to participate. When managers are 
unsure, researchers will make judgements based on 
the framework for mental capacity outlined in the 2005 
Mental Capacity Act for England and Wales23 and in 
keeping with the recommendations of that Act for inclu-
sion research, for residents that lack capacity to provide 
consent to participation, an appropriate person will be 
consulted to make a decision with regards to participa-
tion in the study.
This study will be conducted in parallel to the main 
PEACH study. In addition to the routine collection 
of EQ-5D-5L and HowRu from residents recruited to 
PEACH, proxy responses to EQ-5D-5L and HowRu will 
be gathered from staff. We will include staff such as care 
home assistants, care home manager and registered 
nurses, who know the resident well. We will exclude staff 
employed in a supportive role, such as activity coordina-
tors, since their orientation to supporting residents is 
more variable.
data collection
Data from proxies will be collected on three consecutive 
months. Due to the high staff turnover among care home 
staff, and to enable the influence of carer characteristics 
on the level of agreement to be estimated, data on the carer 
will be gathered at each assessment. Repeated measures 
are required for the final analysis in the PEACH study for 
calculating costs per QALY gained (comparing the inter-
vention with usual care condition) and understanding 
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how the agreement changes at different time points is 
therefore of interest.
Staff proxies will be asked to consider the proxy-resi-
dent’s perspective when completing the questionnaire 
using the following statement: ‘Please rate how you (staff) 
think the resident will rate his/her own health-related 
quality of life, if the resident was to communicate.’24 Both 
self-reported and proxy EQ-5D will be completed on the 
same day to minimise any variations in responses.
The EQ-5D VAS will be used in the study in keeping 
with the recommendations of the EuroQoL group.
Primary analysis
An overall agreement between the self-reported and staff 
proxy responses on the domain levels of the EQ-5D-5L 
and HowRu will be computed. Weighted kappa statistic 
and intraclass correlation (ICC) will be used to calcu-
late the level of agreement for categorical and contin-
uous outcomes respectively. All reliability indices will be 
calculated at the domain levels and overall index scores/
QALYs for the EQ-5D-5L. To calculate the EQ-5D-5L 
index scores, responses from the descriptive system will 
be transformed into index scores derived from the UK 
general population. This will be done using the crosswalk 
value set,25 which maps the 5L descriptive system data 
onto the 3L valuation.
Weighted kappa helps to distinguish between small 
and large difference in agreement ratings assigned to the 
different levels of each domain, but equal importance is 
given to disagreement.26 27 The weighting for kappa will 
be done using linear weight—this assigns the same impor-
tance to the difference between any two categories within 
the response scale.28 The CI for the weighted kappa will 
be calculated by bootstrapping in Stata 15 (Statcorp, 
2015) with 1000 replications. This will be done for each 
time point.
The kappa statistic ranges from −1 to 1, and the strength 
of the agreement will be interpreted with regards to 
published guidelines29 with agreement being:
 ► Poor, if kappa ≤0.00.
 ► Slight, if kappa=0.00 to 0.20.
 ► Fair, if kappa=0.21 to 0.40.
 ► Moderate, if kappa=0.41 to 0.60.
 ► Substantial, if kappa=0.61 to 0.80.
 ► Almost perfect, if kappa ≥0.80.
Unadjusted ICC will be calculated using two-way mixed 
effect Analysis of Variance (ANOVA) model to examine 
the level of agreement between the self-reported and 
proxy responses for the EQ-5D-VAS, EQ-5D index scores 
and total QALYs. ANOVA models are reported to be 
robust to deviations in normality and have been used 
in other QoL agreement studies.16 30 The Bland-Altman 
graph (plotting the mean difference between the EQ-5D-
5L-S (self-report) and EQ-5D-5L-P (proxy) against the 
mean of the two measures) will be constructed to supple-
ment the ICC.
Analysis will be done at each time point for kappa 
and ICC. However, a single ICC value for QALYs will be 
calculated for individuals with data on all three consecu-
tive months as this will be used in practice in the PEACH 
study, where analysis will be done on consecutive measures 
made over time.
To allow for comparability of the level of agreement at 
the domain and index score level; the same benchmarks 
used for kappa will be used for the ICC.
Clustering
Clustering will be adjusted for because the calculation of 
kappa and ICC assumes independence of observations. 
In our study, clustering could occur at three levels at 
each time point. First, at the care home level, where resi-
dents within the same care home have similar character-
istics and are different from those in other care homes. 
Second, at the individual level, where responses are clus-
tered within each resident and lastly, at staff level, where 
staff members within a care home responds on behalf of 
multiple residents.
The ICC value will be calculated allowing for clustering 
using a nested two-way mixed effect model calculated by 
fitting a two-level random effect model with a random 
effect for care home and individuals.
A cluster-adjusted kappa will be calculated using a vari-
ance formula. This will include calculating kappa and its 
variance for each care home, then estimating the within 
cluster variance  σ
2
ω  using the average of the individual 
variances, and between cluster variance  σ
2
b   using the vari-
ance of the individual kappa. Using these estimates, the 
clustered kappa and its variance will be calculated using 
the formulas below:
  ωi =
ni
(1+(ni−1)ρκ)  
Where
 ni = size of cluster  i  
 ρ = intracluster correlation coefficient for kappa
 
 
ρκ =
σ2b
(σ2ω+σ2b ) 
 
Variance of the cluster-adjusted kappa will be obtained 
using the equation below24:
 
 
σ2clustered κ =
Σκi=1 ω
2
i (σ
2
b +
σ2ω
ni
)
(Σκi=1 ωi)
2  
 
The clustered kappa and its variance will then be 
divided by the square root of the number of individuals 
to get the SE. The 95% CI will be calculated using this SE.
Cluster-adjusted kappa (EQ-5D-5L and HowRu domain 
levels) and ICC (EQ-VAS and EQ-5D index scores) will 
be reported for each time point. However, QALYs will be 
presented over time, 3 months, similar to how it will be 
calculated in the PEACH study.
sample size calculation
We need a sample size of 160 residents assuming a kappa 
of 0.145 and a confidence level width of 0.153 derived 
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from a previous study,16 given that 50% of residents will 
have any problems.
secondary analyses
The effect of age, sex and length of stay in care home (for 
residents), length time working in care of older people/
care homes and role/rank (for staff) at baseline on the 
difference between staff and proxy EQ-5D-5L-S scores will 
be analysed using a multilevel mixed effect regression 
model.
To investigate the reliability of using HowRu as a QoL 
measure in the care home population compared with 
EQ-5D-5L, we will assess agreement between these indices 
using weighted kappa statistics. This will involve testing 
the level of agreement between domains with similar 
construct on both scales31 as shown in table 1.
Patient and public involvement
The APRICOT and PEACH studies were developed and 
designed in discussion with both care home sector and 
patient and public involvement (PPI) representatives. 
The initial research proposal and protocol was presented, 
prior to submission for funding, to the Dementia and 
Frail Older Person’s PPI group hosted in the Division of 
Rehabilitation and Ageing, University of Nottingham. 
Amendments were made to the proposal and protocol 
in light of their feedback. The PEACH study team 
includes one PPI and two care home sector representa-
tives who are present at all study management meetings, 
with oversight for the APRICOT sub-study. We keep all 
participating care homes working with PEACH updated 
through quarterly newsletters which will include dissem-
ination of our findings in lay terms as these become 
available.
Ethics and dissemination
This study is part of preparatory work for the larger PEACH 
study. The PEACH study protocol has been reviewed as 
part of good governance by the Nottinghamshire Health-
care Foundation Trust. We aim to publish this study in a 
peer-reviewed journal with international readership and 
disseminate it further using relevant national stakeholder 
networks and specialist societies.
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